NeuroSense Therapeutics Ltd. — POS AM Filings
10 POS AM filings on record
This page lists all POS AM filings submitted to the SEC by NeuroSense Therapeutics Ltd. (NRSNW), sorted by most recent first. Each row links to the full filing on EdgarLookup. NeuroSense Therapeutics Ltd. has filed 10 POS AM documents with the SEC since 2021. To view all SEC filings by NeuroSense Therapeutics Ltd., see the full filings list.
All
20-F
3
424B3
424B4
424B5
6-K
6-K/A
8-A12B
AW
CERT
CORRESP
D
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-3
FWP
POS AM
POS EX
S-8
SC 13G
SC 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| POS AM | POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-1 | 0001213900-25-077471 | Aug 15, 2025 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 4 TO FORM F-1 | 0001213900-25-077468 | Aug 15, 2025 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO 1 TO FORM F-1 | 0001213900-25-031063 | Apr 11, 2025 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 3 TO FORM F-1 | 0001213900-25-031061 | Apr 11, 2025 | — |
| POS AM | POST-EFFECTIVE AMENDMENT | 0001213900-24-083478 | Oct 1, 2024 | — |
| POS AM | POST-EFFECTIVE AMENDMENT | 0001213900-24-030479 | Apr 4, 2024 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 4 TO FORM F-1 | 0001213900-24-030451 | Apr 4, 2024 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 3 TO FORM F-1 | 0001213900-23-092282 | Dec 4, 2023 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-1 | 0001213900-23-089018 | Nov 21, 2023 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1 | 0001213900-22-019892 | Apr 15, 2022 | — |